Prostaglandins in blood of diabetic versus non-diabetic humans

References

1. • Waitzman M.B.
   Possible new concepts relating prostaglandins to various ocular functions.
   Survey Ophthalmol. 1970; 14: 301
   • Google Scholar
2. • Powell E.D.U.
   • Field R.A.
   Diabetic retinopathy and rheumatoid arthritis.
   Lancet. 1964; 2: 17
   • Google Scholar
3. • Hamberg M.
   • Svensson J.
   • Samuelsson B.
   Prostaglandin endoperoxides: A new concept concerning the mode of action and release of prostaglandins.
   in: Proc. Nat. Acad. Sci.71. 1974: 3824
   • Google Scholar
4. • Mundall J.
   • Quintero P.
   • von Kaulla K.N.
   • Harmon R.
   • Austin J.
   Transit monocular blindness and increased platelet aggregability treated with aspirin.
   Neurology. 1972; 22: 280
   • Google Scholar
5. • Smith W.L.
   • Lands W.E.M.
   Stimulation and blockadq of prostaglandin biosynthesis.
   J. Biol. Chem. 1971; 246: 6700
   • Google Scholar
6. • Waitzman M.B.
   • Colley A.M.
   • Nardelli-Olkowska K.
   Metabolic approaches to studies on diabetic microangiopathy.
   Diabetes. 1977; 26: 510
   • Google Scholar
7. • Waitzman M.B.
   • Law M.L.
   Changes in prostaglandin concentration in blood subjected to repetitive freezing and thawing.
   Prostaglandins. 1975; 10: 949
   • Google Scholar
8. • Levine L.
   • Hinkle P.M.
   • Voelkel E.F.
   • Tasjian A.H.
   Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirin.
   Biochem. Biophys. Res. Comm. 1972; 47: 888
   • Google Scholar
9. • Greaves M.W.
   • McDonald-Gibson W.
   Extraction of prostaglandinlike activity from whole human blood.
   Life Sci. 1972; 2 (part 1): 73
   • Google Scholar
10. • Waitzman M.B.
    Prostaglandins and Diabetic Retinopathy.
    Exp. Eye Res. 1973; 16: 307
    • Google Scholar
11. • Jubiz W.
    • Frailey J.
    • Child C.
    • Bartholomew K.
    Physiologic role of prostaglandins of the E (PGE), F(PGF) and AB (PGAB) groups. Estimation by radioimmunoassay in un extracted human plasma.
    Prostaglandins. 1972; 2: 471
    • Google Scholar
12. • Samuelsson B.
    Report on World Health Organization Meeting on Prostaglandins.
    Prostaglandins. 1972; 1: 171
    • Google Scholar
13. • Kolata G.B.
    Thromboxanes: The power behind the prostaglandins?.
    Science. 1975; 190: 770
    • Google Scholar
14. Advances in Prostaglandin and Thromboxane Research. Vol. 1 & 2. Raven Press, New York1976
    • Google Scholar
15. • Gorman R.R.
    • Bunting S.
    • Miller O.V.
    Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
    Prostaglandins. 1977; 13: 377
    • Google Scholar
16. • Tateson J.E.
    • Moncada S.
    • Vane J.R.
    Effects of prostacyclin (PGX) on cyclic-AMP concentrations in human platelets.
    Prostaglandins. 1977; 13: 389
    • Google Scholar
17. • Colwell J.A.
    Indirect evidence mounts for prostaglandin role in natural course of diabetic vascular disease.
    Prostaglandins & Therape. 1975; 1: 1
    • Google Scholar
18. • Dobbie J.G.
    • Kwaan H.C.
    • Colwell J.
    • Suwanwela N.
    The role of platelets in the pathogenesis of diabetic retinopathy.
    Trans. Amer. Acad. Ophthalmol. Otol. 1973; 77: 43
    • Google Scholar
19. • Leopold I.H.
    Chapter 14 in NINDB Monograph 4. NIH, 1967: 144
    • Google Scholar
20. • Leopold I.H.
    POB programming and diabetes.
    Sight Sav. Rev. 1975; 45: 31
    • Google Scholar
21. • Shoch D.
    • March W.
    • Engerman R.
    Platelet aggregation in experimental diabetic retinopathy.
    in: Ocular Therapy. Vol. 8. Wiley Publishers, New York1975
    • Google Scholar
22. • Salzman E.W.
    • Weinberger H.
    Role of cyclic-AMP in platelet function.
    Adv. Cyclic Nucleotide Res. 1972; 1: 231
    • Google Scholar
23. • Salzman E.W.
    • Neri L.
    Cyclic 3′,5′-adenosine monophosphate in human blood platelets.
    Nature. 1969; 224: 609
    • Google Scholar
24. Prostaglandins. 1977; 13: 375
    • Google Scholar
25. • Moncada S.
    • Gryglewski R.
    • Bunting S.
    • Vane J.R.
    An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
    Nature. 1976; 263: 663
    • Google Scholar
26. • Samuelsson B
    The role of prostaglandin endoperoxides and thromboxanes in human platelets.
    in: Silver M.J. Smith J.B. Kocsis J.J. Prostaglandins in Hematology. Spectrum Publications, New York1977: 1
    • Google Scholar